CPHI Germany Exhibition Review | Gathered by "Unity", Advancing for "Innovation"

From October 28th to 30th, 2025, the global pharmaceutical industry event—CPHI Worldwide Europe—successfully concluded at the Frankfurt Exhibition Centre in Germany. As the largest and most influential gathering in the pharmaceutical industry, CPHI brought together 2,400 exhibitors and 62,000 professional attendees from over 160 countries, attracting top pharmaceutical companies, innovative biotechnology firms, and industry leaders from around the world. The CPHI exhibition serves not only as a platform to showcase the latest technologies and achievements but also as a critical bridge for gaining insights into industry trends and forging strategic collaborations.

At this year's event, Lianhe Aigen dispatched a strong team of business and technical experts who engaged in intensive and productive face-to-face discussions with existing and potential partners from North America, Europe, Asia, and other regions. At our exhibition booth, the team comprehensively and vividly presented the company's end-to-end global CDMO services through professional explanations and case studies. From early-stage drug discovery and process development to preclinical and clinical-stage production, all the way to commercial supply, we demonstrated our core value as a reliable and efficient strategic partner to international clients. This was achieved through our world-class quality systems, robust global supply chain capabilities, and deeply customized solutions, further strengthening the company's professional brand image worldwide.

Participation in CPHI 2025 Germany was not merely a showcase of our brand but also an opportunity to sow the seeds for future collaborations. Through direct dialogue with global innovation partners, we gained a clearer understanding of cutting-edge R&D trends and market demands, reinforcing our commitment to continuously enhancing our international service capabilities.

Looking ahead, we will continue to deepen and refine our global service network, steadfastly upholding our mission of "Empower Global Innovative Medicines and Contribute to Human Health" We look forward to translating the consensus built during this exhibition into tangible collaborative outcomes. Together with our global partners, we aim to accelerate the delivery of more innovative drugs and reach new heights in the pursuit of advancing human health!